Amirsaeed Sabeti Aghabozorgi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Amirsaeed Sabeti Aghabozorgi has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Alireza Bahiraee
Department of Medical Genetics, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
2 shared publications Amirhossein Bahreyni
2 shared publications- Reza Jafarzadeh Esfehani
Blood Borne Infections Research Center, Academic Center for Education, Culture and Research (ACECR)- Khorasan Razavi, Mashhad, Iran
2 shared publications Afsane Bahrami
Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran
1 shared publication- Alireza Pasdar
Department of Genetics and Molecular Medicine, Faculty of Medicine, Mashhad University of Medical Science, Mashhad, Iran
1 shared publication Amir Avan
Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Modern Sciences and Technologies, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
1 shared publication
Latest Publications
- 18 March 2021
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 22 (5) , 303-318
Role of miRNA Gene Variants in the Susceptibility and Pharmacogenetics of Colorectal Cancer
Colorectal cancer (CRC) is one of the most significant challenges in the field of cancer pathology. MiRNAs are among the genetic factors associated with the disease. Although many studies have revi...
- 18 March 2021
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 22 (5) , 303-318
Role of miRNA Gene Variants in the Susceptibility and Pharmacogenetics of Colorectal Cancer
Colorectal cancer (CRC) is one of the most significant challenges in the field of cancer pathology. MiRNAs are among the genetic factors associated with the disease. Although many studies have revi...
- 5 July 2019
- Published by Wiley in Journal of Cellular Physiology
- Vol. 234 (12) , 21796-21809
Circulating exosomal miRNAs in cardiovascular disease pathogenesis: New emerging hopes
Cardiovascular diseases (CVDs) are one of the leading causes of morbidity and mortality. Standard therapies have failed to significantly increase patients’ survival. Moreover, the majority of conventional screening procedures are ineffective for the diagnosis of CVDs at early stages. Accumulating evidence suggests that numerous cell types release a class of nano‐sized vesicles named exosomes into the extracellular space. Exosomes are widely distributed in various body fluids and contain a number of diverse biomolecules such as proteins, lipids, and both mRNA and noncoding RNAs which reflect host‐cell molecular architecture. MicroRNAs (miRNAs), which can be found in exosomes, could be taken up by both neighboring and distal cells. Not only has recent evidence indicated the regulatory role of exosomal miRNAs in the pathogenesis of CVD, but it has also been shown that differential expression of exosomal miRNAs in CVDs has made them promising biomarkers for early detection of CVDs. Owing to these remarkable features, exosomal miRNAs have emerged as hot spots in research. This review summarizes the role of exosomal miRNAs in the pathogenesis of CVDs and discusses their potential application in the clinical setting as both therapeutic and diagnostic tools.
- 5 July 2019
- Published by Wiley in Journal of Cellular Physiology
- Vol. 234 (12) , 21796-21809
Circulating exosomal miRNAs in cardiovascular disease pathogenesis: New emerging hopes
Cardiovascular diseases (CVDs) are one of the leading causes of morbidity and mortality. Standard therapies have failed to significantly increase patients’ survival. Moreover, the majority of conventional screening procedures are ineffective for the diagnosis of CVDs at early stages. Accumulating evidence suggests that numerous cell types release a class of nano‐sized vesicles named exosomes into the extracellular space. Exosomes are widely distributed in various body fluids and contain a number of diverse biomolecules such as proteins, lipids, and both mRNA and noncoding RNAs which reflect host‐cell molecular architecture. MicroRNAs (miRNAs), which can be found in exosomes, could be taken up by both neighboring and distal cells. Not only has recent evidence indicated the regulatory role of exosomal miRNAs in the pathogenesis of CVD, but it has also been shown that differential expression of exosomal miRNAs in CVDs has made them promising biomarkers for early detection of CVDs. Owing to these remarkable features, exosomal miRNAs have emerged as hot spots in research. This review summarizes the role of exosomal miRNAs in the pathogenesis of CVDs and discusses their potential application in the clinical setting as both therapeutic and diagnostic tools.
- 25 April 2019
- Published by Wiley in Journal of Cellular Physiology
- Vol. 234 (11) , 19480-19493
The role of inflammation and its related microRNAs in breast cancer: A narrative review
Breast cancer is recognized as the most common type of cancer among women with a high rate of mortality all over the world. Over the past years, growing attention has been regarded to realize more about the mechanisms underlying the disease process. It is revealed that the progression of breast cancer may be strongly linked to chronic inflammation owing to the role of inflammatory factors in genetic instability and subsequent cancer predisposition. Although the association between breast cancer and inflammatory pathways has been well‐defined now, only recent evidence pointed towards the inflammation‐related microRNAs (miRNAs) as potential biomarkers and therapeutic targets involved in the crosstalk of multiple pathways during breast cancer development. Moreover, the practical interactions between these miRNAs and inflammatory factors are also a little characterized. In this review, we intended to describe the effects of predominant inflammatory pathways such as cytokines, phosphoinositide 3‐kinase/protein kinase B, and nuclear factor kappa B in association with tumor promoting and tumor suppressing miRNAs on breast cancer progression. Providing new studies in the field of combining biomarkers for early diagnosis, prognosis, and monitoring breast cancer are very important. Notably, understanding the underlying mechanisms of miRNAs as a possible link between inflammation and tumorigenesis may offer a novel insight for combating this epidemic.
- 25 April 2019
- Published by Wiley in Journal of Cellular Physiology
- Vol. 234 (11) , 19480-19493
The role of inflammation and its related microRNAs in breast cancer: A narrative review
Breast cancer is recognized as the most common type of cancer among women with a high rate of mortality all over the world. Over the past years, growing attention has been regarded to realize more about the mechanisms underlying the disease process. It is revealed that the progression of breast cancer may be strongly linked to chronic inflammation owing to the role of inflammatory factors in genetic instability and subsequent cancer predisposition. Although the association between breast cancer and inflammatory pathways has been well‐defined now, only recent evidence pointed towards the inflammation‐related microRNAs (miRNAs) as potential biomarkers and therapeutic targets involved in the crosstalk of multiple pathways during breast cancer development. Moreover, the practical interactions between these miRNAs and inflammatory factors are also a little characterized. In this review, we intended to describe the effects of predominant inflammatory pathways such as cytokines, phosphoinositide 3‐kinase/protein kinase B, and nuclear factor kappa B in association with tumor promoting and tumor suppressing miRNAs on breast cancer progression. Providing new studies in the field of combining biomarkers for early diagnosis, prognosis, and monitoring breast cancer are very important. Notably, understanding the underlying mechanisms of miRNAs as a possible link between inflammation and tumorigenesis may offer a novel insight for combating this epidemic.